Ushbu ish iqtibos qilgan ishlar

23 ta ish

Ish: Posttreatment ⁶⁸Ga-FAP-2286 PET/CT Parameters for Response and Survival Assessment After ¹⁷⁷Lu-FAP-2286 Radioligand Therapy in Advanced Solid Tumors

1. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

   Richard L. Wahl, Heather A. Jacene, Yvette L. Kasamon +1

   Sharh maqola20095 iqtibos

   ABIABI:AkademIndex/2026.other.413769

2. Feasibility and therapeutic potential of [177Lu]Lu-FAPI-2286 in patients with advanced metastatic sarcoma

   Seyedeh Somayyeh Banihashemian, Mohammad Esmaeil Akbari, Elahe Pirayesh +5

   Maqola20244 iqtibos

   ABIABI:AkademIndex/2026.other.340335

3. The role of fibroblast activation protein in health and malignancy

   Allison A. Fitzgerald, Louis M. Weiner

   Sharh maqolaOAOchiq kirish20203 iqtibos

   ABIABI:AkademIndex/2026.other.144643

4. Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results

   Richard P. Baum, Christiane Schuchardt, Aviral Singh +12

   Maqola20213 iqtibos

   ABIABI:AkademIndex/2026.other.340321

5. Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers

   Majid Assadi, Seyed Javad Rekabpour, Esmail Jafari +9

   Maqola20213 iqtibos

   ABIABI:AkademIndex/2026.other.340322

6. Sarlavhasiz

   Boshqa2 iqtibos

   ABIABI:AkademIndex/2026.other.340313

7. Sarlavhasiz

   Boshqa2 iqtibos

   ABIABI:AkademIndex/2026.other.340329

8. Sarlavhasiz

   Boshqa2 iqtibos

   ABIABI:AkademIndex/2026.other.340334

9. Sarlavhasiz

   Boshqa2 iqtibos

   ABIABI:AkademIndex/2026.other.466615

10. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.838598

11. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.838607

12. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.838608

13. Exploratory Analysis of [68Ga]Ga-FAP-2286 PET/CT Quantitative Parameters for Predicting Response to [177Lu]Lu-FAP-2286 Therapy in Non-small Cell Lung Cancer

    Min Fan, Xinyue Guo, Guangfu Liu +3

    MaqolaPeptidase Inhibition and AnalysisClinical Nuclear Medicine20251 iqtibos

    ABIABI:AkademIndex/2025.article.001457

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.933361

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.933362

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.933363

17. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.933364

18. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.933365

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.933366

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.933367

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.933368

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.933369

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.933370